Search Results 671-680 of 18475 for Prednisone
Phase trial treatment. - Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone ...
Treatment with corticosteroids within 2 weeks of the first dose of study drug, except for the equivalent of ≤ 10 mg prednisone per day or corticosteroids ...
Use of systemic corticosteroids (> 10 mg prednisone or equivalent) within 15 days (except for prophylaxis for radiodiagnostic contrast reactions), or other ...
... (prednisone ≤ 10 mg/day is allowed). Participants with laboratory values at screening, without transfusions and hematopoietic growth factor support, defined ...
-Chronic corticosteroid use of ≤ 20 mg prednisone equivalent per day, on a stable dose for ≥ 4 weeks prior to registration. -Any life-threatening illness ...
... prednisone therapy at ≥ 1 mg/kg/day, a trial of calcineurin inhibitor for=> 3 months or a contraindication/intolerance to such therapy (diabetes ...
Inhaled or topical steroids, and adrenal replacement doses ≤ 10 mg daily prednisone or equivalent are permitted in the absence of active autoimmune disease.
Chronic prednisone > 5mg/day. Concurrent opportunistic infections. Pregnancy. Gastrointestinal bleeding refractory to medical/endoscopic treatment ...
NOTE: Patients on low dose prednisone (=< 10 mg) for treatment of conditions other than CLL are eligible. Patients who have received more than 1 prior ...
exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to randomization. Note: Other protocol ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.